These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7363464)

  • 61. [Evaluation of the specificity of specificity of prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostate pathology].
    Morote Robles J; Ruibal Morell A; De Torres Mateos JA; Soler Roselló A
    Actas Urol Esp; 1987; 11(2):176-9. PubMed ID: 2441575
    [No Abstract]   [Full Text] [Related]  

  • 62. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
    Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
    Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum prostatic acid phosphatase determination in prostatic diseases: a critical comparison of an enzymatic and a radioimmunologic assay.
    Van Cangh PJ; Opsomer R; De Nayer P
    J Urol; 1982 Dec; 128(6):1212-5. PubMed ID: 6185698
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Measurement of prostatic acid phosphatase in diseases of the prostate (author's transl)].
    Suzuki K; Fukushi M; Ishibashi T; Ishizuka J; Kayanuma H; Ogasawara K; Kondoh T; Nogami S; Kinoshita K; Kawakami R; Okada R; Kinoshita F; Inada T; Hosoda K
    Rinsho Hoshasen; 1982 May; 27(5):559-64. PubMed ID: 7109288
    [No Abstract]   [Full Text] [Related]  

  • 65. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
    Salo JO; Rannikko S; Haapiainen R
    Br J Urol; 1990 Aug; 66(2):188-92. PubMed ID: 1697205
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
    Bauer HW; Schmeller NT
    Urology; 1984 Mar; 23(3):247-51. PubMed ID: 6199879
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Radioimmunoassay of prostatic acid phosphatase in serum used "PAP Eiken" kit].
    Hashimoto N; Maruoka Y; Harada M
    Horumon To Rinsho; 1982 Aug; 30(8):869-72. PubMed ID: 7139985
    [No Abstract]   [Full Text] [Related]  

  • 68. Development and evaluation of a new solid-phase direct immunoenzyme assay for prostatic acid phosphatase.
    Gericke K; Kohse KP; Pfleiderer G; Flüchter SH; Bichler KH
    Clin Chem; 1982 Apr; 28(4 Pt 1):596-602. PubMed ID: 7042116
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Fundamental and clinical study of PAP 'Eiken' (author's transl)].
    Higuchi Y; Kida T
    Kaku Igaku; 1981 Dec; 18(10):1451-7. PubMed ID: 6176743
    [No Abstract]   [Full Text] [Related]  

  • 70. Elevation of serum prostatic acid phosphatase levels after prostatic massage.
    Wadström J; Huber P; Rutishauser G
    Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bone marrow acid phosphatase by radioimmunoassay.
    Belville WD; Cox HD; Mahan DE; Olmert JP; Mittemeyer BT; Bruce AW
    Cancer; 1978 Jun; 41(6):2286-91. PubMed ID: 77719
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enzyme measurements by mass: an interim review of the clinical efficacy of some mass measurements of prostatic acid phosphatase and isoenzymes of creatine kinase.
    Henderson AR; Nealon DA
    Clin Chim Acta; 1981; 115(1):9-32. PubMed ID: 7021004
    [No Abstract]   [Full Text] [Related]  

  • 73. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 74. Prostatic trauma and release of acid phosphatase. Radioimmunochemical and enzymatic comparison.
    Belville WD; Mahan DE; Clements JC; McLeod DG
    Urology; 1980 Aug; 16(2):168-71. PubMed ID: 6157244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative performance of three radioimmunoassays for prostatic acid phosphatase.
    Farnsworth WE; Gonder MJ; Cartagena R; Steinbach JJ
    Urology; 1980 Aug; 16(2):165-7. PubMed ID: 6157243
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnostic accuracy of four assays of prostatic acid phosphatase. Comparison using receiver operating characteristic curve analysis.
    Carson JL; Eisenberg JM; Shaw LM; Kundel HL; Soper KA
    JAMA; 1985 Feb; 253(5):665-9. PubMed ID: 3881609
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A solid-phase radioimmunoassay for human prostatic acid phosphatase.
    Foti AG; Herschman H; Cooper JF
    Cancer Res; 1975 Sep; 35(9):2446-52. PubMed ID: 1170944
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Secretion into and elimination from blood circulation of prostate specific acid phosphatase, measured by radioimmunoassay.
    Vihko P; Schroeder FH; Lukkarinen O; Vihko R
    J Urol; 1982 Jul; 128(1):202-4. PubMed ID: 6180187
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
    Fossà SD; Skinningsrud A; Kaalhus O; Engeset A
    Br J Urol; 1983 Jun; 55(3):306-11. PubMed ID: 6850249
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.
    Dejter SW; Martin JS; McPherson RA; Lynch JH
    Urology; 1988 Oct; 32(4):288-92. PubMed ID: 2459831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.